Stock UniverseDerived research view · source repositories remain read-only

Replimune Group, Inc. (REPL)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.92
Global Rank
1823
Market Cap
631.68M
Latest Close
9.47
RS Composite
36.52% · G#225

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
175.29%
3M
17.35%
6M
-8.24%
1Y
-2.27%
3Y
-50.13%
5Y
-75.70%
10Y
-37.53%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 4.58M · 30-day average: 7.98M · Max drawdown over stored range: -96.77%

Research Snapshot

Relative Strength vs SPX

RS Composite36.52%
20D RS182.90%
60D RS10.90%
120D RS-11.05%
Global RS Rank225 · 93.29% percentile
Watch+Speculative RS Rank128 · 93.90% percentile
Group ScopeWatch+Speculative
Primary RS Rank38 · 91.70% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank244 / 701
Primary Percentile65.34
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-02-03n/an/a-325.91M-314.85M-3.44-513.16M12.18M-525.33M92Mn/an/an/an/an/a269.14M47.63M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$-3.44-2.8xn/an/a$-5.73-1.7x$-5.60-1.7x

Shares Diluted: 92M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-77.148-115.144-174.166-232.853-259.854
Free Cash Flow-63.781-84.516-130.32-191.129-198.937
Free Cash Flow Per Share-1.379-1.619-2.239-2.871-2.469
EPS (Diluted) GAAP-1.748579-2.260694-2.993901-3.241615-3.069566
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)46.24952.212358.21366.569980.5641
Shares Change (YoY)34.988%12.894%11.493%14.356%21.022%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q32026-02-03n/an/a-71.87Mn/a-70.93Mn/a-0.7792.19M269.14M47.63Mprocessed
2026 Q22025-11-06n/an/a-84.29Mn/a-83.10Mn/a-0.9091.92M323.64M47.21Mprocessed
2026 Q12025-08-07n/an/a-90.42Mn/a-86.69Mn/a-0.9591.52M403.34M46.79Mprocessed
2025 Q42025-05-22n/an/a-79.33Mn/a-74.13Mn/a-0.8290.92M483.80M46.38Mprocessed
2025 Q32025-02-12n/an/a-66.02Mn/a-66.34Mn/a-0.7983.50M536.54M45.96Mprocessed
2025 Q22024-11-12n/an/a-58.92Mn/a-53.05Mn/a-0.6878.57M432.06M45.57Mprocessed
2025 Q12024-08-08n/an/a-57.37Mn/a-53.77Mn/a-0.7869.19M469.12M45.19Mprocessed
2024 Q42024-05-16n/an/a-58.76Mn/a-55.08Mn/a-0.8366.68M420.67M44.81Mprocessed
2024 Q32024-02-08n/an/a-56.54Mn/a-51.12Mn/a-0.7766.65M466.35M44.43Mprocessed
2024 Q22023-11-07n/an/a-63.83Mn/a-60.04Mn/a-0.9066.58M496.76M29.16Mprocessed
2024 Q12023-08-03n/an/a-55.65Mn/a-49.55Mn/a-0.7566.37M539.10M28.91Mprocessed
2023 Q42023-05-18n/an/a-52.99Mn/a-49.24Mn/a-0.7566.00M583.39M28.65Mprocessed
2023 Q32023-02-09n/an/a-41.63Mn/a-39.69Mn/a-0.6957.86M616.37M28.39Mprocessed
2023 Q22022-11-03n/an/a-41.58Mn/a-43.10Mn/a-0.7954.77M371.82Mn/aprocessed
2023 Q12022-08-04n/an/a-40.88Mn/a-42.25Mn/a-0.7854.21M395.08Mn/aprocessed
2022 Q42022-05-19n/an/a-31.99Mn/a-31.70Mn/a-0.6052.54M395.65Mn/aprocessed
2022 Q32022-02-03n/an/a-29.70Mn/a-29.67Mn/a-0.5752.32M420.17Mn/aprocessed
2022 Q22021-11-04n/an/a-29.25Mn/a-29.36Mn/a-0.5652.08M435.77Mn/aprocessed
2022 Q12021-08-06n/an/a-27.38Mn/a-27.31Mn/a-0.5351.91M458.33Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.